Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer
Head & Neck · 2025
DOI: 10.1002/hed.70101 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Head & Neck, 2025. Verfasst von Raisa Chowdhury und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Geriatric Assessment, Malnutrition, Nutrition Assessment. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Malnutrition is associated with worse outcomes in head and neck cancer (HNC). The geriatric nutritional risk index (GNRI) may predict postoperative morbidity and survival, but its role remains underexplored.
Methods
An ambispective study of patients undergoing HNC surgery at two academic centers (2015–2024) was performed. Preoperative GNRI was categorized into moderate‐to‐high risk (< 92), low risk (92–98), and no risk (> 98). Outcomes included 90‐day mortality, treatment intolerance, overall survival, and disease‐free survival. Analyses were performed using multivariable logistic and Cox regression adjusted for age, Charlson Comorbidity Index (CCI), tumor stage, primary tumor site, and percutaneous endoscopic gastrostomy (PEG) status. Patients with prior head and neck cancer or prior radiation were excluded.
Results
Among 312 treatment‐naïve surgical patients, 13% were moderate‐to‐high GNRI risk and 8% low risk. Moderate‐to‐high GNRI risk had higher major adverse events (57% vs. 36% in no‐risk), greater treatment intolerance (61% vs. 41%), and a trend toward higher 90‐day mortality (11% vs. 4%). On multivariable models adjusted for tumor site and pathologic stage, moderate‐to‐high GNRI risk was associated with higher odds of 90‐day mortality (OR 2.99, 95% CI 1.01–9.31; p = 0.048) and treatment intolerance (OR 2.35, 95% CI 1.21–4.56; p = 0.012). Cox regression showed shorter overall (HR 2.28, 95% CI 1.44–3.62; p < 0.001) and disease‐free survival (HR 1.87, 95% CI 1.20–2.91; p = 0.005).
Conclusions
The GNRI predicted treatment intolerance and poorer survival in patients with operable HNC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
- Department of Otolaryngology-Head and Neck Surgery, McGill University, Montreal, Quebec, Canada.
- Department of Medical Oncology, McGill University, Montreal, Quebec, Canada.
- Department of Radiation Oncology, McGill University, Montreal, Quebec, Canada.
ORCID-Profile: Raisa Chowdhury, Nader Sadeghi, Marco A Mascarella
Zitieren
APA
Chowdhury, R., Mlynarek, A. M., Richardson, K., Sadeghi, N., Hier, M. P., Wurzba, S., Esfahani, K., Bouganim, N., Sultanem, K., Shenouda, G., Tsien, C., & Mascarella, M. A. (2025). Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer. Head & Neck. https://doi.org/10.1002/hed.70101
Vancouver
Chowdhury R, Mlynarek AM, Richardson K, Sadeghi N, Hier MP, Wurzba S, et al. Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer. Head & Neck. 2025. doi:10.1002/hed.70101
BibTeX
@article{Chowdhury2025,
author = {Chowdhury, Raisa and Mlynarek, Alex M and Richardson, Keith and Sadeghi, Nader and Hier, Michael P and Wurzba, Sabrina and Esfahani, Khashayar and Bouganim, Nathaniel and Sultanem, Khalil and Shenouda, George and Tsien, Christina and Mascarella, Marco A},
title = {Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.70101}
}
EUVIMED